Clinical Trials Browser

Recruiting × Mesothelioma, Malignant × Nivolumab × Clear all

Mesothelioma, Malignant, Mesothelioma

NCT04400539 2025-09-25

IMPALA

Phase 2 Recruiting

20 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT06362369 2025-09-17

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Phase 1/2 Recruiting

126 enrolled

DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Turcot syndrome, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms

Clinical Trials

eVOLVE-Meso

IMPALA

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy